Literature DB >> 29297692

Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs.

Bregje Leyman1, Hanne Huysmans1, Séan Mc Cafferty1,2, Francis Combes1,2, Eric Cox3, Bert Devriendt3, Niek N Sanders1,2.   

Abstract

Synthetic mRNA is becoming increasingly popular as an alternative to pDNA-based gene therapy. Currently, multiple synthetic mRNA platforms have been developed. In this study we investigated the expression kinetics and the changes in mRNA encoding cytokine and chemokine levels following intradermal electroporation in pigs of pDNA, self-replicating mRNA, and modified and unmodified mRNA. The self-replicating mRNA tended to induce the highest protein expression, followed by pDNA, modified mRNA, and unmodified mRNA. Interestingly, the self-replicating mRNA was able to maintain its high expression levels during at least 12 days. In contrast, the expression of pDNA and the nonreplicating mRNAs dropped after respectively one and two days. Six days after intradermal electroporation a dose-dependent expression was observed for all vectors. Again, also at lower doses, the self-replicating mRNA tended to show the highest expression. All the mRNA vectors, including the modified mRNA, induced elevated levels of mRNA encoding cytokines and chemokines in the porcine skin after intradermal electroporation, while no such response was noticed after intradermal electroporation of the pDNA vector.

Entities:  

Keywords:  innate immune response; luciferase expression; mRNA-therapeutics; pDNA; pigs

Mesh:

Substances:

Year:  2018        PMID: 29297692     DOI: 10.1021/acs.molpharmaceut.7b00722

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

Review 1.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

2.  In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation.

Authors:  Sean Mc Cafferty; Joyca De Temmerman; Tasuku Kitada; Jacob R Becraft; Ron Weiss; Darrell J Irvine; Mathias Devreese; Siegrid De Baere; Francis Combes; Niek N Sanders
Journal:  Mol Ther       Date:  2020-11-11       Impact factor: 11.454

3.  Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs.

Authors:  Zifu Zhong; Séan McCafferty; Lisa Opsomer; Haixiu Wang; Hanne Huysmans; Joyca De Temmerman; Stefan Lienenklaus; João Paulo Portela Catani; Francis Combes; Niek N Sanders
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

4.  Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine.

Authors:  Zifu Zhong; João Paulo Portela Catani; Séan Mc Cafferty; Liesbeth Couck; Wim Van Den Broeck; Nina Gorlé; Roosmarijn E Vandenbroucke; Bert Devriendt; Sebastian Ulbert; Lieselotte Cnops; Johan Michels; Kevin K Ariën; Niek N Sanders
Journal:  Vaccines (Basel)       Date:  2019-08-23

Review 5.  Perspectives on RNA Vaccine Candidates for COVID-19.

Authors:  Pobitra Borah; Pran Kishore Deb; Nizar A Al-Shar'i; Lina A Dahabiyeh; Katharigatta N Venugopala; Vinayak Singh; Pottathil Shinu; Snawar Hussain; Satyendra Deka; Balakumar Chandrasekaran; Da'san M M Jaradat
Journal:  Front Mol Biosci       Date:  2021-03-25

Review 6.  Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic.

Authors:  Samagra Jain; Abhijeet Venkataraman; Marissa E Wechsler; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2021-10-09       Impact factor: 17.873

Review 7.  Messenger RNA vaccines for cancer immunotherapy: progress promotes promise.

Authors:  Amanda L Huff; Elizabeth M Jaffee; Neeha Zaidi
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 19.456

Review 8.  A new generation of vaccines based on alphavirus self-amplifying RNA.

Authors:  María Cristina Ballesteros-Briones; Noelia Silva-Pilipich; Guillermo Herrador-Cañete; Lucia Vanrell; Cristian Smerdou
Journal:  Curr Opin Virol       Date:  2020-09-05       Impact factor: 7.090

Review 9.  Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.

Authors:  An-Katrien Minnaert; Helena Vanluchene; Rein Verbeke; Ine Lentacker; Stefaan C De Smedt; Koen Raemdonck; Niek N Sanders; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2021-07-26       Impact factor: 17.873

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.